Opioid-potentiated Volative Anaesthetic Vs. Remifentanil And Propofol During Abdominal Aortic Aneurysm Surgery

NCT ID: NCT00538421

Last Updated: 2013-03-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

193 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-03-31

Study Completion Date

2013-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparing 2 different anaesthetic methods during abdominal aortic aneurysm surgery. The patients will be followed up 30 days postoperative. Number of patients included will be 200. Perioperative details will be analyzed.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aortic Diseases Abdominal Aneurysm Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Group Type ACTIVE_COMPARATOR

Propofol

Intervention Type DRUG

Infusion intravenously (IV) 0-10 mg/kg/h

2

Group Type ACTIVE_COMPARATOR

Sevoflurane

Intervention Type DRUG

0,7-1,5 MAC

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Propofol

Infusion intravenously (IV) 0-10 mg/kg/h

Intervention Type DRUG

Sevoflurane

0,7-1,5 MAC

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who are planned for open, elective abdominal aortic aneurysm surgery.
* ASA group 1-4.

Exclusion Criteria

* Patients below 18 years.
* Patients who are included in other pharmaceutical studies.
* Opioids-, benzodiazepins-, antiepileptic drugs-, alcohol- and α2-agonists abuse.
* Pregnant and breastfeeding women.
* Patients with familiar history of malignant hyperthermia.
* Patients with known hypersensitivity for opioids, propofol or volative anaesthetics.
* Patients with considerable arrythmia (atrial fibrillation /atrial flutter is acceptable). Uncontrolled hypertension, serious psychiatric disease.
* Patients with unstable angina pectoris or myocardial infarction last month before inclusion.
* Acute abdominal aortic surgery. Acute dissection or rupture.
* Planned laparoscopic abdominal aortic aneurysm surgery.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Oslo University Hospital

OTHER

Sponsor Role collaborator

Sykehuset i Vestfold HF

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Espen Lindholm

Chief consultant

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Espen Lindholm, MD

Role: STUDY_DIRECTOR

Sykehuset i Vestfold HF

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sykehuset i Vestfold HF

Tønsberg, , Norway

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Norway

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2007-000002-79 (Eudract)

Identifier Type: -

Identifier Source: secondary_id

17089 (NSD)

Identifier Type: -

Identifier Source: secondary_id

S-07294b (REK)

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Sevoflurane, Propofol, Postoperative Pain
NCT01437462 COMPLETED PHASE4
Sevoflurane in Cardiac Surgery
NCT00821262 COMPLETED PHASE4